Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Wiener Klinische Wochenschrift
|
September 20, 2023
[General recommendations for the management of glomerular diseases-2023]
Martin Windpessl, Philipp Gauckler, Emanuel Zitt, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnosis and treatment of glomerular diseases with a membranoproliferative glomerulonephritis (MPGN) pattern of injury]
Michael Rudnicki, Martin Windpessl, Kathrin Eller, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnosis and treatment of Minimal Change Disease in adults-2023]
Philipp Gauckler, Heinz Regele, Kathrin Eller, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnostic and therapy of lupus nephritis - 2023]
Balazs Odler, Marion J Pollheimer, Andreas Kronbichler, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnosis and treatment of focal-segmental glomerulosclerosis-2023]
Philipp Gauckler, Emanuel Zitt, Heinz Regele, et al.
Wiener Klinische Wochenschrift
|
September 29, 2025
[Recommendations for the Diagnosis and Treatment of Chronic Kidney Disease (CKD) by the Austrian Society of Nephrology]
Sara H Ksiazek, Martin Windpessl, Emanuel Zitt, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnosis and therapy of granulomatosis with polyangiitis and microscopic polyangiitis-2023: consensus of the Austrian society of nephrology (ÖGN) and Austrian society of rheumatology (ÖGR)]
Balazs Odler, Martin Windpessl, Kathrin Eller, et al.
Kidney International
|
October 27, 2018
A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health
Andreas Vychytil, Rebecca Herzog, Paul Probst, et al.
Frontiers in Immunology
|
November 15, 2021
The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis
Balazs Odler, Martin Windpessl, Marcell Krall, et al.
Kidney International Reports
|
February 12, 2024
Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design
Lisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Wiener Klinische Wochenschrift
|
September 20, 2023
[General recommendations for the management of glomerular diseases-2023]
Martin Windpessl, Philipp Gauckler, Emanuel Zitt, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnosis and treatment of glomerular diseases with a membranoproliferative glomerulonephritis (MPGN) pattern of injury]
Michael Rudnicki, Martin Windpessl, Kathrin Eller, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnosis and treatment of Minimal Change Disease in adults-2023]
Philipp Gauckler, Heinz Regele, Kathrin Eller, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnostic and therapy of lupus nephritis - 2023]
Balazs Odler, Marion J Pollheimer, Andreas Kronbichler, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnosis and treatment of focal-segmental glomerulosclerosis-2023]
Philipp Gauckler, Emanuel Zitt, Heinz Regele, et al.
Wiener Klinische Wochenschrift
|
September 29, 2025
[Recommendations for the Diagnosis and Treatment of Chronic Kidney Disease (CKD) by the Austrian Society of Nephrology]
Sara H Ksiazek, Martin Windpessl, Emanuel Zitt, et al.
Wiener Klinische Wochenschrift
|
September 20, 2023
[Diagnosis and therapy of granulomatosis with polyangiitis and microscopic polyangiitis-2023: consensus of the Austrian society of nephrology (ÖGN) and Austrian society of rheumatology (ÖGR)]
Balazs Odler, Martin Windpessl, Kathrin Eller, et al.
Kidney International
|
October 27, 2018
A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health
Andreas Vychytil, Rebecca Herzog, Paul Probst, et al.
Frontiers in Immunology
|
November 15, 2021
The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis
Balazs Odler, Martin Windpessl, Marcell Krall, et al.
Kidney International Reports
|
February 12, 2024
Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design
Lisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, et al.
Page
of 7